Gepotidacin in Breast Milk of Lactating Women
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study measures how much of an antibiotic called gepotidacin passes into breast milk. Researchers will give healthy breastfeeding women a single dose and collect milk samples to understand if it's safe for nursing infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy woman between 18 and 50 years old who is actively breastfeeding or pumping
- Be at least 28 days after delivery with established milk supply and no serious delivery complications
- Able to stop breastfeeding your infant for about 3 days after the dose (you'll pump and store milk beforehand for bottle feeding)
- Willing to fully express milk from both breasts multiple times during the milk collection period
- Have a BMI of 36 kg/m² or less, weigh at least 45 kg, and be generally healthy with no serious medical conditions
- Not currently pregnant, not a smoker (or quit at least 1 month ago), and not taking certain medications that could interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of an investigational antibiotic called gepotidacin in children aged 2 to 12 who have a bacterial infection or are taking antibiotics to prevent one. The goal is to see how the medicine works in young patients.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
This study checks how much of an antibiotic called fosfomycin passes into breast milk when given intravenously to healthy nursing mothers. The goal is to understand if it's safe for breastfeeding women to receive this antibiotic.
This study measures how common medicines move through a breastfeeding parent’s milk and checks safety in both the parent and breastfed baby. It may help doctors use these medicines more safely while you continue breastfeeding.
This study looks at how the drug cimetidine gets into breast milk after healthy mothers take it. The goal is to find out how much reaches the baby and how it affects their body.
This trial studies how drugs for tuberculosis (TB) enter breast milk and affect the mother and baby. It helps find the right dose and safety for women who are breastfeeding, even if they do not have TB themselves.
Hear when a new Urinary Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.